BamSEC and AlphaSense Join Forces
Learn More

Aligos Therapeutics Inc.

NASDAQ: ALGS    
Share price (12/20/24): $39.84    
Market cap (12/20/24): $143 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1(C)
from 10-Q 6 pages Aligos Therapeutics, Inc. 2024 Employment Inducement Award Plan Restricted Stock Unit Award Grant Notice
12/34/56
EX-10.1(B)
from 10-Q 9 pages Aligos Therapeutics, Inc. 2024 Employment Inducement Award Plan Stock Option Grant Notice
12/34/56
EX-10.1(A)
from 10-Q 21 pages Aligos Therapeutics, Inc. 2024 Employment Inducement Award Plan
12/34/56
EX-10.3
from 10-Q 4 pages Aligos Therapeutics, Inc. Non-Employee Director Compensation Program
12/34/56
EX-10.2
from 10-Q Pdf Courtesy Copy
12/34/56
EX-10.2
from 10-Q 5 pages Aligos Therapeutics, Inc. September 4, 2024
12/34/56
EX-10.1
from 10-Q 4 pages Aligos Therapeutics, Inc. Non-Employee Director Compensation Program
12/34/56
EX-10.1
from 8-K 2 pages Amendment to the Aligos Therapeutics, Inc. 2020 Incentive Award Plan Effective June 27, 2024
12/34/56
EX-10.18
from 10-K 10 pages Separation and General Release Agreement
12/34/56
EX-10.17
from 10-K 12 pages Aligos Therapeutics, Inc. Change in Control and Severance Agreement
12/34/56
EX-10.16
from 10-K 12 pages Aligos Therapeutics, Inc. Change in Control and Severance Agreement
12/34/56
EX-10.1
from 8-K 42 pages Securities Purchase Agreement
12/34/56
EX-10.16
from 10-K 43 pages Lease Agreement
12/34/56
EX-10.1
from 10-Q 7 pages Consulting Agreement
12/34/56
EX-10.15
from S-1 7 pages Consulting Agreement
12/34/56
EX-10.4
from 10-Q 11 pages Aligos Therapeutics, Inc. Change in Control and Severance Agreement
12/34/56
EX-10.3
from 10-Q 5 pages Julian Symons 7 Azalea Lane San Carlos, Ca 94070 Re: Confirmatory Employment Letter
12/34/56
EX-10.2
from 10-Q 13 pages Amended and Restated Employment Agreement
12/34/56
EX-10.1
from 10-Q 13 pages Amended and Restated Employment Agreement
12/34/56
EX-10.12
from S-1/A 18 pages Indemnification Agreement
12/34/56